The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
AI-powered cardiometabolic wellness platform for India’s workforce
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Subscribe To Our Newsletter & Stay Updated
